In our study six patients with recalcitrant
idiopathic LCV, two of them with clinically
palpable purpura was treated with systemic
agents for eight months without clinical
improvement, respond well to PUVA after 4
weeks of treatment. Four patients with livedoid
vasculitis respond to PUVA therapy.